CLINICAL TRIALS PROFILE FOR RELAMORELIN
✉ Email this page to a colleague
Clinical Trials for Relamorelin
| Trial ID | Title | Status | Sponsor | Phase | Summary |
|---|---|---|---|---|---|
| NCT01955616 ↗ | A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation | Terminated | Michael J. Fox Foundation for Parkinson's Research | Phase 2 | The purpose of this study, called MOVE-PD, is to investigate how individuals with Parkinson's disease (PD) and chronic constipation (CC) respond to RM-131 as compared to placebo. The study will look at how well RM-131 affects the frequency of spontaneous bowel movements over a 14-day period. The study will also evaluate the safety and tolerability of the study drug and evaluate whether the study drug relieves the uncomfortable GI symptoms related to chronic constipation in patients who are unsatisfied with other therapies they have tried for constipation. |
| NCT01955616 ↗ | A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation | Terminated | Motus Therapeutics, Inc. | Phase 2 | The purpose of this study, called MOVE-PD, is to investigate how individuals with Parkinson's disease (PD) and chronic constipation (CC) respond to RM-131 as compared to placebo. The study will look at how well RM-131 affects the frequency of spontaneous bowel movements over a 14-day period. The study will also evaluate the safety and tolerability of the study drug and evaluate whether the study drug relieves the uncomfortable GI symptoms related to chronic constipation in patients who are unsatisfied with other therapies they have tried for constipation. |
| NCT02137642 ↗ | Study to Evaluate the Effects of RM-131 in Patients With Chronic Constipation | Completed | Mayo Clinic | Phase 1 | The purpose of this study is to evaluate safety and tolerability as well as the effects of RM-131 on colonic motor and sensory effects in patients with chronic constipation. |
| NCT02137642 ↗ | Study to Evaluate the Effects of RM-131 in Patients With Chronic Constipation | Completed | Motus Therapeutics, Inc. | Phase 1 | The purpose of this study is to evaluate safety and tolerability as well as the effects of RM-131 on colonic motor and sensory effects in patients with chronic constipation. |
| NCT02357420 ↗ | Safety and Efficacy of Relamorelin Administered to Participants With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis | Completed | Allergan | Phase 2 | The purpose of this study is to evaluate the effects of multiple dose regimens of relamorelin on vomiting episodes, gastric emptying and gastroparesis symptoms in participants with Type 1 and Type 2 diabetes mellitus and gastroparesis. Study drug (relamorelin and placebo) will be administered subcutaneously in a blinded fashion. |
| NCT02357420 ↗ | Safety and Efficacy of Relamorelin Administered to Participants With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis | Completed | Motus Therapeutics, Inc. | Phase 2 | The purpose of this study is to evaluate the effects of multiple dose regimens of relamorelin on vomiting episodes, gastric emptying and gastroparesis symptoms in participants with Type 1 and Type 2 diabetes mellitus and gastroparesis. Study drug (relamorelin and placebo) will be administered subcutaneously in a blinded fashion. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for Relamorelin
Condition Name
Clinical Trial Locations for Relamorelin
Trials by Country
Clinical Trial Progress for Relamorelin
Clinical Trial Phase
Clinical Trial Sponsors for Relamorelin
Sponsor Name
